XML 99 R9.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Cash Flows Consolidated Statements of Cash Flows - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows - operation activities:    
Net earnings $ 374 $ 7,036
Non-cash items -    
Share-based plans expense 160 150
Depreciation and amortization 1,643 1,531
Asset Impairment Charges 106 63
Customer financing valuation adjustments 249 (3)
Gain on dispositions, net (296) (76)
Other charges and credits, net 190 158
Changes in assets and liabilities -    
Accounts receivable 315 10
Unbilled receivables (1,053) (1,732)
Advances and progress billings 2,355 3,457
Inventories 9,565 173
Other current assets (224) (5)
Accounts payable 1,626 1,181
Accrued liabilities 5,495 890
Income taxes receivable, payable and deferred (989) (252)
Other long-term liabilities (577) 1
Pension and other postretirement plans (570) (89)
Customer financing, net 391 (175)
Other 144 403
Net cash (used)/provided by operating activities (226) 12,375
Cash flows - investing activities:    
Property, plant and equipment additions (1,387) (1,227)
Property, plant and equipment reductions 334 117
Acquisitions, net of cash acquired (492) (250)
Contributions to investments (1,439) (2,145)
Proceeds from investments 967 1,369
Purchase of distribution rights (20) (56)
Other (10) (5)
Net cash used by investing activities (2,047) (2,197)
Cash flows - financing activities:    
New borrowings 19,621 4,696
Debt repayments (8,978) (4,029)
Contributions from noncontrolling interests 7 35
Stock options exercised 51 70
Employee taxes on certain share-based payment arrangements (241) (247)
Common shares repurchased (2,651) (8,415)
Dividends paid (3,473) (2,976)
Net cash provided/(used) by financing activities 4,336 (10,866)
Effect of exchange rate changes on cash and cash equivalents, including restricted (27) (37)
Net increase/(decrease) in cash & cash equivalents, including restricted 2,036 (725)
Cash & cash equivalents, including restricted, at beginning of year 7,813 8,887
Cash & cash equivalents, including restricted, at end of period 9,849 8,162
Restricted Cash and Cash Equivalents [1] (86) (128)
Cash and cash equivalents at end of period $ 9,763 $ 8,034
[1]
Reflects amounts restricted in support of our workers’ compensation programs, employee benefit programs, and insurance premiums.